Zhang, Z., Li, L., Ge, Y., Chen, A., Diao, S., Yang, Y., Chen, Q., Zhou, Y., Shao, J., Meng, F., Yu, L., Tian, M., Qian, X., Lin, Z., Xie, C., Liu, B., & Li, R. (2025). Verteporfin-Mediated In Situ Nanovaccine Based on Local Conventional-Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect. Advanced science (Weinheim, Baden-Wurttemberg, Germany), e2413387. Advance online publication. 通讯作者
Lei D, Wang W, Zhao J, Zhou Y, Chen Y, Dai J, Qiu Y, Qi H, Li C, Liang B, Liu B, Wang Q, Li R. An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment. Mater Today Bio. 2025 Feb 24;31:101611. 通讯作者
Yen YT, Zhang Z, Chen A, Qiu Y, Liu Q, Wang Q, Li C, Wang C, Qian X, Shao J, Meng F, Yu L, Liu B, Li R. Enzymatically responsive nanocarriers targeting PD-1 and TGF-β pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy. J Nanobiotechnology. 2025 Feb 19;23(1):124. 通讯作者
Bei Y, Huang Y, Wu N, Li Y, Xu R, Liu B, Li R. A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors. EMBO Mol Med. 2025 Feb;17(2):365-383. 通讯作者
Li C, Lei D, Huang Y, Jing Y, Wang W, Cen L, Wei Z, Chen A, Feng X, Wang Y, Yu L, Chen Y, Li R. Remodeling the tumor immune microenvironment through hydrogel encapsulated G-Rh2 in situ vaccine and systemic immunotherapy. Mater Today Bio. 2024 Sep 27;29:101281. 通讯作者
Diao S, Zhang Z, Zhao S, Li Q, Zhang X, Yang X, Xu Z, Liu M, Zhou W, Li R, Xie C, Fan Q. Dual-Activatable Nano-Immunomodulator for NIR-II Fluorescence Imaging-Guided Precision Cancer Photodynamic Immunotherapy. Adv Sci (Weinh). 2024 Dec;11(45):e2409833. 通讯作者
Li Y, Wang Q, Li L, Yuan S, Chen H, Li R, Liu F. Exploration of the immunologic characteristics of KIT/PDGFRA wild-type gastrointestinal stromal tumor and potential application of neoantigen vaccination. Chin Med J (Engl). 2024 Nov 5;137(21):2627-2629. 通讯作者
Ge YC, Min LM, Liu Q, Wang XL, Wang SF, Chen J, Kong WT, Wu SJ, Zhou GX, Wang TT, Liu BR, Li RT. Neo-adjuvant radiation and intratumoral immunotherapy followed by surgery-NARIS trial for extremity soft tissue sarcoma. Future Oncol. 2024;20(30):2233-2240. 通讯作者
Lu H, Wang J, Chen Z, Wang J, Jiang Y, Xia Z, Hou Y, Shang P, Li R, Liu Y, Xie J. Engineered Macrophage Membrane-Coated S100A9-siRNA for Ameliorating Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2024 Nov;11(41):e2403542. 通讯作者
Sun M, Shi T, Tuerhong S, Li M, Wang Q, Lu C, Zou L, Zheng Q, Wang Y, Du J, Li R, Liu B, Meng F. An Immunomodulator-Boosted Lactococcus Lactis Platform For Enhanced In Situ Tumor Vaccine. Adv Healthc Mater. 2024 Nov;13(28):e2401635. 通讯作者
Dai J, Zhu J, Zhu L, Wang X, Bao J, Chen X, Zhou Y, Min L, Qi H, Liu Q, Shen J, Tian M, Shao J, Li R, Liu B. An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: 'R-ISV-FOLactis' trial. Future Oncol. 2024;20(20):1393-1400. 通讯作者
Wang Q, Peng R, Qi H, Xu R, Liu W, Meng F, Du S, Yu L, Wei J, Liu F, Li R. Liposome-based in situ antigen-modification strategy for universal T-cell-receptor engineered T cell in cancer immunotherapy. MedComm (2020). 2024 Jul 7;5(7):e618. 通讯作者
Shi T, Sun M, Tuerhong S, Li M, Wang J, Wang Y, Zheng Q, Zou L, Lu C, Sun Z, Zou Z, Shao J, Du J, Li R, Liu B, Meng F. Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumors. Biomaterials. 2024 Sep;309:122607. 通讯作者
Jing Y, Wang C, Li C, Wei Z, Lei D, Chen A, Li X, He X, Cen L, Sun M, Liu B, Xue B, Li R. Development of a manganese complex hyaluronic acid hydrogel encapsulating stimuli-responsive Gambogic acid nanoparticles for targeted Intratumoral delivery. Int J Biol Macromol. 2024 Jun;270(Pt 2):132348. 通讯作者
Min L, Wang X, Chen A, Zhou Y, Ge Y, Dai J, Chang X, Sun W, Liu Q, Zhou X, Tian M, Kong W, Zhu J, Shen J, Liu B, Li R. Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future Oncol. 2024;20(17):1139-1149. 通讯作者
Wang C, Jing Y, Yu W, Gu J, Wei Z, Chen A, Yen YT, He X, Cen L, Chen A, Song X, Wu Y, Yu L, Tao G, Liu B, Wang S, Xue B, Li R. Bivalent Gadolinium Ions Forming Injectable Hydrogels for Simultaneous In Situ Vaccination Therapy and Imaging of Soft Tissue Sarcoma. Adv Healthc Mater. 2023 Oct;12(26):e2300877. 通讯作者
Tian J, Wang H, Lu C, Liu L, Zhang X, Xie Y, Li R, Lv X, Fu D, Zhang L, Fang X, Wang X, Hu J, Liu X, Huang X, Zhao Q, Luo N, Tang H, Zhong Z, He Y, Li L. Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study. Lung Cancer. 2023 Jul;181:107255.
Qu R, He D, Wu M, Li H, Liu S, Jiang J, Wang X, Li R, Wang S, Jiang X, Zhen X. Afterglow/Photothermal Bifunctional Polymeric Nanoparticles for Precise Postbreast-Conserving Surgery Adjuvant Therapy and Early Recurrence Theranostic. Nano Lett. 2023 May 24;23(10):4216-4225.
Shen J, Yan J, Du J, Li X, Wei J, Liu Q, Yong H, Wang X, Chang X, Ding Z, Sun W, Liu C, Zhu S, Guo J, Li H, Liu Y, Zhang W, Liu Z, Li R, Liu B. Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors. Front Immunol. 2023 Mar 28;14:1133689. 通讯作者
Qiu Y, Wang X, Fan Y, Bao Y, Meng F, Liu B, Li R. A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next-generation sequencing prospect. Thorac Cancer. 2023 May;14(14):1316-1319. 通讯作者
Wang X, Liu B, Li R. Development and validation of a nomogram for predicting survival in patients with malignant myofibroblastic tumor. Cancer Med. 2023 Apr;12(8):9260-9271. 通讯作者
Liu F, Wang Q, Li Y, Li L, Shi J, Fan X, Pan Q, Li R. KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients. J Gastroenterol Hepatol. 2023 Jul;38(7):1123-1130. 通讯作者
Wang X, Meng F, Li X, Xue L, Chen A, Qiu Y, Zhang Z, Li L, Liu F, Li Y, Sun Z, Chu Y, Xu R, Yu L, Shao J, Tian M, Qian X, Liu Q, Liu B, Li R. Nanomodified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid Tumors. Adv Sci (Weinh). 2023 Apr;10(12):e2205044.通讯作者
Wang X, Gao J, Li C, Xu C, Li X, Meng F, Liu Q, Wang Q, Yu L, Liu B, Li R. In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis.Mater Today Bio. 2022 May 31;15:100305.通讯作者
Wang Q, Yen Y,Xie C, Liu F,Liu Q, Wei J,Yu L, Wang L, Meng F, Li R, Liu B. Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells. Drug Delivery. 2021,28(1): 510-519.通讯作者
Wang Q, Liu F, Wang L, Xie C, Wu P, Du S, Zhou S, Sun Z, Liu Q, Yu L, Liu B, Li R.Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.Int J Nanomedicine.2020 Feb 26;15:1283-1295.通讯作者
Wang X, Meng F, Yen Y, Li R, Liu B. Nanotechnology-Based CAR-T Strategies for Improving Efficacy and Safety of Tumor Immunotherapy. Adv. Funct. Mater. 2020, 2004713通讯作者
Yen Y, Wang X, Zhang H, Wang C, Lin Z, Xie C, Liu Q, Wang L, Yu L, Xie L, Lv X, Liu B, Li R. Prominent Enhancement of Cisplatin Efficacy with Optimized Methoxy Poly(ethyleneglycol)-Polycaprolactone Block Copolymeric Nanoparticles. J. Biomed. Nanotechnol. 2020; 16, 335–343. 通讯作者
Zhang Y, Wang L, Li R, Liu B. The emerging development of tumor mutational burden in patients with NSCLC. Future Oncol. 2020;16(9):469-481. 通讯作者
Wang Q, Liu F, Wang L, Xie C, Wu P, Du S, Zhou S, Sun Z, Liu Q, Yu L, Liu B, Li R. Author information. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells. Int J Nanomedicine. 2020 (15):1283-1295. 通讯作者
Zhang Y, Wang L, Gao J, Li L, Jiang P, Lv X, Yu L, Yang J, Li R, Liu B. Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma. Curr Oncol. 2019;26(2):e121-e127.通讯作者
Gao A, Teng Y, Seyiti P, Yen Y, Qian H, Xie C, Li R, Lin Z. Using Omniscan-Loaded Nanoparticles as a Tumor-Targeted MRI Contrast Agent in Oral Squamous Cell Carcinoma by Gelatinase-Stimuli Strategy. Nanoscale Res Lett. 2019 Dec 30;14(1):395. doi: 10.1186/s11671-019-3214-5.通讯作者
Wu P, Liu Q, Wang Q, Qian H, Yu L, Liu B, Li R. Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth. Int J Nanomedicine. 2018;13:5405-5418.通讯作者
Li R, Yan J, Xie L, Zhang Y, Gao J, Liu Q, Lin Z, Jiang P, Qian H, Yang M, Wu F, Jiang X, Liu B, Wang L. Facile Optimization and Evaluation of PEG–PCL Block Copolymeric Nanoparticles for Anticancer Drug Delivery Using Copolymer Hybrids and Histoculture Drug Response Assays. J. Biomed. Nanotechnol. 2018,14(2), 321–330
Li R, Liu B, Gao J, The application of nanoparticles in diagnosis and theranostics of gastric cancer. Cancer Lett, 2016 Cancer Lett. 2016;386:123-130.
Lu N, Li R, Liu Q, Hu B, Xu X, Ji C, Han X, Wang P, Liu B. Antitumor and antimetastatic effects of pemetrexed-loaded targeted nanoparticles in B16 bearing mice. Drug Deliv. 2016;23(7):2566-2574. 共同第一作者
Wu F, Li R, Yang M, Yue G, Wang H, Liu Q, Cui F, Wu P, Ding H, Yu L, Qian X, Liu B. Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2'-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics. Cancer Lett. 2015, 363(1):7–16共同第一作者
Wang Q, Wu P, Ren W, Xin K, Yang Y, Xie C, Yang C, Liu Q, Yu L, Jiang X, Liu B, Li R, Wang L. Comparative studies of salinomycin-loaded nanoparticles prepared by nanoprecipitation and single emulsion method. Nanoscale Res Lett. 2014 Jul 15;9(1):351. doi: 10.1186 / 1556-276X-9-351.通讯作者
Cui F, Li R, Liu Q, Wu P, Hu W, Yue G, Ding H, Yu L, Qian X, Liu B. Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer. Cancer Lett. 2014 Apr 28;346(1):53-62. 共同第一作者
